ROXILID

Semisynthetic second generation macrolide antibiotic

learn more

ROXILID

Semisynthetic second generation macrolide antibiotic

The drug is prescribed to treat infections caused by microorganisms susceptible to roxithromycin:

  • ENT organs (tonsillitis, laryngitis, pharyngitis, sinusitis, otitis media); 
  • respiratory tract infections (pneumonia, acute and chronic bronchitis);
  • skin and soft tissue (common acne, furunculus, carbuncle, pyoderma);
  • urogenital infections (except gonorrhoea, including urethritis, cervicovaginitis).
More in instructions (Ukrainian version)
INN
Roxithromycinum
Package
150 mg,10 x 150 mg
Form of release
Tablets
АТС class
J01F A06

See also

Specialized publications intended for medical institutions and doctors Limitations in obtaining information